U.S. Markets open in 1 hr 27 mins

Novogen Limited (NVGN)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.880.00 (0.00%)
At close: 3:59PM EDT
People also watch
NYMXPRANPBMDGENEMEIP
Full screen
Previous Close0.88
Open0.89
Bid0.00 x
Ask1.79 x 8000
Day's Range0.86 - 0.89
52 Week Range0.70 - 2.44
Volume10,982
Avg. Volume38,850
Market Cap17.3M
Beta1.13
PE Ratio (TTM)-1.68
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Yahoo Finance3 months ago

    Democrats found a way to speak Trump's language in pharma debate

    The members of congress introduced a bill related to the talk last week. A quartet of Democratic members of Congress introduced a bill last week in harmony with President Donald Trump’s campaign promises of lowering prescription drug costs. Entitled the Improving Access to Affordable Prescription Drugs Act, the 128-page bill aims to overhaul what many view as a broken system that has seen bipartisan outrage over skyrocketing prices.

  • Benzinga3 months ago

    Novogen Receives $4.4M R&D Tax Rebate

    Novogen Ltd (NASDAQ: NVGN ) is pleased to confirm receipt of $4.4m from the Australian Taxation Office under the R&D Tax Incentive Program for the financial year ending 30 June 2016. These funds will be ...

  • Benzinga8 months ago

    Novogen Licenses Phase II-ready Molecule from Genentech for Development in Glioblastoma for $5M Upfront , Plus Milestones

    Novogen Ltd (NASDAQ: NVGN ) today announced that it has entered into a worldwide licensing agreement with Genentech, a member of the Roche Group (OTC: RHHBY ), to develop and commercialise GDC-0084, a ...